Login to Your Account

Chinese investors buy stake in Italian biopharma NMS

By Pearl Liu
Staff Writer

Thursday, January 4, 2018

HONG KONG – A consortium of Chinese investors will acquire a 90 percent stake in innovative oncology treatment developer Group NMS Co. Ltd., of Milan, Italy.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription